Status | Study |
Not yet recruiting |
Study Name: ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy Condition: Pulmonary Arterial Hypertension (PAH) Date: 2017-05-02 Interventions: Biological: Allogeneic Human Cardiosphere-Derived Stem Cells |
Recruiting |
Study Name: Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension Condition: Pulmonary Arterial Hypertension Date: 2017-04-04 Interventions: Procedure: Patients with Pulmonary Arterial Hypertension 2 repeated measurement session to enable assess |
Not yet recruiting |
Study Name: Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension. Condition: Pulmonary Arterial Hypertension Date: 2017-03-06 Interventions: Drug: Selexipag Film-coated ta |
Not yet recruiting |
Study Name: A Mobile Health Intervention in Pulmonary Arterial Hypertension Condition: Pulmonary Arterial Hypertension Idiopathic Pulmonary Arterial Hypertension Date: 2017-02-21 Interventions: Device: Smartphone Text Messaging |
Completed |
Study Name: TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH) Condition: Pulmonary Arterial Hypertension Date: 2017-02-09 Interventions: Drug: Remodulin® (Intravenous Treprostinil) Intravenous treprostinil supplied in 20-mL vials and di |
Not yet recruiting |
Study Name: Impact of Rehabilitation Program on PAH Patients Treated With Macitentan. Condition: Pulmonary Arterial Hypertension Date: 2017-02-05 Interventions: Other: Exercise program patients who are stable on Macitentan therapy (received in both groups before en |
Not yet recruiting |
Study Name: ADAPT - A Patient Registry of the Real-world Use of Orenitram® Condition: Pulmonary Arterial Hypertension Date: 2017-02-02 Interventions: Drug: Oral treprostinil Sustained-release oral tablets for TID administration |
Withdrawn |
Study Name: Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH Condition: Pulmonary Arterial Hypertension Date: 2017-01-06 Interventions: Drug: Parenteral Remodulin (treprostinil) injection |
Not yet recruiting |
Study Name: Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension Condition: Pulmonary Arterial Hypertension Date: 2016-12-19 Interventions: Drug: Oral Treprostinil Sustai |
Recruiting |
Study Name: Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA) Condition: Pulmonary Arterial Hypertension Date: 2016-11-14 Interventions: Drug: macitentan used in open |